EQUITY RESEARCH MEMO
Deseret Labs
Generated 5/11/2026
Executive Summary
Conviction (model self-assessment)55/100
Deseret Laboratories, Inc. (DLI) is a full-service custom manufacturer serving the nutraceutical, pharmaceutical, over-the-counter (OTC), and homeopathic industries. Based in Salt Lake City, Utah, and founded in 2017, the company operates state-of-the-art facilities and partners closely with clients to ensure quality, on-time delivery, and value. DLI’s reputation for integrity and solution-minded capabilities has made it a trusted partner for global brands seeking reliable contract manufacturing. The company’s focus on diverse product categories positions it well to serve a broad customer base, though it operates in a competitive outsourcing market.
Upcoming Catalysts (preview)
- Q4 2026Facility Expansion or New Capability Announcement70% success
- TBDKey Client Partnership or Long-Term Agreement50% success
- Q2 2026Regulatory Certification (FDA Inspection Clearance)80% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)